Lun Yang
Molecular Biology · 2010–2014
A researcher in the Science corpus: 3 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 48 citations into it
- Computational Theory and Mathematics — 31 citations into it
- Pharmacology — 9 citations into it
Whom Lun Yang trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Lun Yang's perspective
Ordered by how strongly the researchers Lun Yang trusts endorse each paper. Same corpus, a different order for every researcher.
- Predicting new molecular targets for known drugs
- The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
- Drug Target Identification Using Side-Effect Similarity
- Discovery of drug mode of action and drug repositioning from transcriptional responses (Proceedings of the National Academy of Sciences of the United States of America)
- Human Disease-Drug Network Based on Genomic Expression Profiles (PLoS ONE)
- Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis (PLoS Comput. Biol.)
- A side effect resource to capture phenotypic effects of drugs
- Discovery and preclinical validation of drug indications using compendia of public gene expression data (Science Translational Medicine)
- New uses for old drugs (Nature)
- Network biology: understanding the cell's functional organization
Their papers
- Computational Drug Repositioning: From Data to Therapeutics (2013) — 340 citations
- Systematic prediction of drug combinations based on clinical side-effects (2014) — 62 citations
- The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models (2010) — 549 citations